---
figid: PMC6178360__41467_2018_6366_Fig5_HTML
figtitle: Metastatic adrenocortical carcinoma
organisms:
- NA
pmcid: PMC6178360
filename: 41467_2018_6366_Fig5_HTML.jpg
figlink: /pmc/articles/PMC6178360/figure/Fig5/
number: F5
caption: Key molecular pathways altered in metastatic ACC. Network of canonical pathways
  that are significantly altered in metastatic ACC based on ingenuity pathway analysis
  (IPA) (a). Pathways that are predominantly altered in metastatic ACC including ERBB4
  signaling (b), retinoic acid receptor signaling (c), G-protein-coupled receptor
  signaling (d), and platelet-derived growth factor receptor signaling (e). The number
  within each box represents the percentage of gene mutations in these tumors
papertitle: Metastatic adrenocortical carcinoma displays higher mutation rate and
  tumor heterogeneity than primary tumors.
reftext: Sudheer Kumar Gara, et al. Nat Commun. 2018;9:4172.
year: '2018'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.8319668
figid_alias: PMC6178360__F5
figtype: Figure
organisms_ner:
- Homo sapiens
redirect_from: /figures/PMC6178360__F5
ndex: 10f57781-de9f-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6178360__41467_2018_6366_Fig5_HTML.html
  '@type': Dataset
  description: Key molecular pathways altered in metastatic ACC. Network of canonical
    pathways that are significantly altered in metastatic ACC based on ingenuity pathway
    analysis (IPA) (a). Pathways that are predominantly altered in metastatic ACC
    including ERBB4 signaling (b), retinoic acid receptor signaling (c), G-protein-coupled
    receptor signaling (d), and platelet-derived growth factor receptor signaling
    (e). The number within each box represents the percentage of gene mutations in
    these tumors
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - AR
  - AN
  - ATM
  - STOM
  - PRKAA1
  - PRKAA2
  - PRKAB1
  - PRKAB2
  - PRKAG1
  - PRKAG2
  - PRKAG3
  - SMAD1
  - SMAD4
  - SMAD5
  - SMAD6
  - SMAD7
  - SMAD9
  - SMAD2
  - SMAD3
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - ERBB4
  - RARG
  - RBP3
  - E2F1
  - NCOR2
  - NCOR1
  - DR1
  - PLCG1
  - PLCG2
  - PRRT2
  - PRKCA
  - PRKCB
  - PRKCD
  - PRKCE
  - PRKCG
  - PRKCH
  - PRKCI
  - PRKCQ
  - PRKCZ
  - PRKD3
  - SMARCA2
  - NCOA1
  - EP300
  - CREBBP
  - FZD4
  - NMUR1
  - LPAR3
  - LGR6
  - MRGPRX3
  - MRGPRX4
  - GPR151
  - OXER1
  - GPRC6A
  - MRGPRX1
  - VN1R17P
  - GPR166P
  - GRM1
  - GRM2
  - GRM3
  - GRM4
  - GRM5
  - GRM6
  - GRM7
  - GRM8
  - CASR
  - GABBR1
  - GABBR2
  - GPR156
  - GPR158
  - GPR179
  - GPRC5A
  - GPRC5B
  - GPRC5C
  - GPRC5D
  - PDGFRB
  - PDGFRA
  - GNAS
  - GNAL
  - GNAQ
  - GNA11
  - GNA14
  - GNA15
  - GNAO1
  - GNAI1
  - GNAI2
  - GNAI3
  - GNAT1
  - GNAT2
  - GNAT3
  - GNAZ
  - ABL1
  - ADCY3
  - ADCY8
  - ADCY9
  - EIF2AK2
  - STAT3
  - CYLD
  - TNMD
  - MFT2
  - NANOG
  - PC
  - Dobamine
  - NANOG
  - Rheomatoid Arthritis
---
